Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05832879 · ClinicalTrials.gov registry record · NA
Telehealth Treatment for Opioid Use Disorders
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT05832879 is a NA study that has completed, run by Yale University. The registered enrollment target is 33 participants.
The verdict
NCT05832879, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
This study aims to use an Opioid Use Disorder (OUD) Telehealth Platform to reduce overdose events. This telehealth platform will be pilot tested to evaluate its preliminary efficacy in terms of motivating engagement in medications for OUD (MOUD), as well as its feasibility, acceptability and satisfaction to both first responders/providers and participants.
Interventions
- BEHAVIORAL OUD Telehealth Platform
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2024-05-01 |
| Est. Completion | 2025-07-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05832879
The ClinicalTrials.gov registry entry for NCT05832879 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which OUD Telehealth Platform is the first listed.
NCT05832879 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05832879 about?
NCT05832879 is a clinical study titled "Telehealth Treatment for Opioid Use Disorders". This study aims to use an Opioid Use Disorder (OUD) Telehealth Platform to reduce overdose events. This telehealth platform will be pilot tested to evaluate its preliminary efficacy in terms of motivating engagement in medications for OUD (MOUD), as well as its feasibility, acceptability and satisfa...
What is the current status of trial NCT05832879?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2024-05-01. Estimated completion is 2025-07-24.
What interventions are being tested in trial NCT05832879?
The interventions under investigation include: OUD Telehealth Platform (BEHAVIORAL).
Who is sponsoring clinical trial NCT05832879?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.